Literature DB >> 5030814

Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.

W D Meriwether, N R Bachur.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5030814

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  25 in total

1.  Comparative effects of doxorubicin and 4'-epi-doxorubicin on nucleic acid metabolism and cytotoxicity in a human tumor cell line.

Authors:  O Cantoni; P Sestili; F Cattabeni; C Geroni; F Giuliani
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Adriamycin-Induced Models of VACTERL Association.

Authors:  D Mc Laughlin; P Hajduk; P Murphy; P Puri
Journal:  Mol Syndromol       Date:  2013-02

3.  [Macronucleolar transformation of a leukemic lymphosarcoma. Clinical morphologic and molecular biologic parameters].

Authors:  S Seeber; M Rodenbeck; K P Brucksch; C G Schmidt
Journal:  Blut       Date:  1975-01

4.  In vivo effects of doxorubicin on kinase C in cultured cells.

Authors:  M Otsuka; H Shigeoka; H C Yang
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Modulation of antitumoral antibody-dependent cellular cytotoxicity and natural killer activity by Adriamycin and daunorubicin.

Authors:  R W Pfeifer; H B Bosmann
Journal:  Agents Actions       Date:  1982-12

6.  Adriamycin and daunorubicin inhibition of mutant T4 DNA polymerases.

Authors:  M F Goodman; M J Bessman; N R Bachur
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

Review 7.  Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma.

Authors:  Miriam Sharpe; Stephanie E Easthope; Gillian M Keating; Harriet M Lamb
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 8.  Anthracyclines in the treatment of cancer. An overview.

Authors:  G N Hortobágyi
Journal:  Drugs       Date:  1997       Impact factor: 9.546

9.  Effects of N-trifluoroacetyladriamycin-14-valerate (AD-32) on human bladder tumor cell lines.

Authors:  H B Niell; R F Hunter; H G Herrod; M Israel
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma.

Authors:  Francesca Cainelli; Alfredo Vallone
Journal:  Biologics       Date:  2009-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.